文献速递疼痛医学

简短疼痛再加工疗法治疗纤维肌痛的可行性、可接受性与初步疗效预试验

Brief pain reprocessing therapy for fibromyalgia: a feasibility, acceptability, and preliminary efficacy pilot.
PubMed 文献 · Reg Anesth Pain Med · 2025-09-18

本研究为单臂开放标签预试验,35名纤维肌痛成人接受三次远程医疗行为干预(BPRT),33人(94.3%)完成方案。完成者平均疼痛强度、疼痛干扰和疼痛相关恐惧显著下降,3个月随访时42.3%报告「明显改善」或「非常明显改善」。BPRT可行且可接受,初步疗效积极,需更大随机对照试验验证。

要点

  • BPRT为三次远程医疗行为干预,针对纤维肌痛的中枢敏化机制。
  • 33/35(94.3%)完成治疗,可接受性评分高(62.0/70)。
  • 完成者疼痛强度、干扰和恐惧在3个月内显著下降,效应量中到大。

核心结论

  • BPRT在纤维肌痛成人中可行且可接受,并显示出降低疼痛、疼痛干扰和疼痛相关恐惧的初步疗效。

研究设计与样本

  • 单臂、开放标签预试验,35名纤维肌痛成人启动治疗,接受三次一对一远程医疗干预,并在干预前及干预后1、2、3个月完成在线问卷。

主要发现

  • 33名参与者(94.3%)完成BPRT方案。
  • 完成者平均疼痛强度显著下降(B=-0.645,95%CI -0.896至-0.395,p<0.001;1个月d=0.56,2个月d=0.80,3个月d=0.89)。
  • 完成者疼痛干扰显著下降(B=-2.19,95%CI -3.06至-1.31,p<0.001;1个月d=0.76,2个月d=1.02,3个月d=1.06)。
  • 完成者疼痛相关恐惧显著下降(B=-2.29,95%CI -3.07至-1.51,p<0.001;1个月d=0.60,2个月d=0.88,3个月d=1.04)。
  • 3个月随访时,42.3%的完成者报告「明显改善」或「非常明显改善」。

关键数值与推荐

  • BPRT可接受性评分(Treatment Acceptability/Adherence Scale)为62.0/70。

临床怎么用

  • 对于纤维肌痛患者,可考虑将简短远程医疗行为干预(BPRT)作为辅助治疗选项,但需在更大随机对照试验验证前谨慎应用。

局限性

  • 单臂、开放标签设计,样本量小(35人启动,33人完成),缺乏对照组,无法排除安慰剂效应或自然病程影响。
  • 需更大随机对照试验严格评估BPRT的疗效和机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fibromyalgia (FM) is a common, disabling, and costly nociplastic pain condition. Most frontline treatments show modest effects in reducing pain in FM, which may be due to a mismatch between the mechanisms of existing interventions and mechanisms underlying nociplastic pain. The current study was a single-arm, open-label trial examining the feasibility, acceptability, and preliminary efficacy of a novel, three-session telehealth behavioral intervention (Brief Pain Reprocessing Therapy (BPRT)). BPRT incorporates psychological techniques specifically targeting the putative mechanisms of nociplastic pain in a brief, telehealth format. METHODS: 35 adults with FM initiated treatment. Participants were asked to complete three one-on-one intervention sessions via telehealth and online questionnaires at four time points (pre-intervention and at 1, 2, and 3 months post-intervention) assessing average pain intensity, pain interference, and pain-related fear. RESULTS: 33 participants (94.3%) completed the BPRT protocol. Acceptability ratings for BPRT were high (62.0 out of 70 on the Treatment Acceptability/Adherence Scale). BPRT completers reported significant reductions in average pain intensity (B=-0.645, 95% CI -0.896 to -0.395, p<0.001; 1-month d=0.56, 2-month d=0.80, 3-month d=0.89), pain interference (B=-2.19, 95% CI -3.06 to -1.31, p<0.001; 1-month d=0.76, 2-month d=1.02, 3-month d=1.06), and pain-related fear (B=-2.29, 95% CI -3.07 to -1.51, p<0.001; 1-month d=0.60, 2-month d=0.88, 3-month d=1.04). At the 3-month follow-up, 42.3% of completers reported being 'much improved' or 'very much improved.' CONCLUSIONS: BPRT is feasible and acceptable, with promising preliminary efficacy for reducing pain, pain interference, and pain-related fear in FM. These findings highlight the possibility of reducing FM pain and interference using a brief telehealth intervention. Larger randomized controlled trials are needed to rigorously evaluate the efficacy and mechanisms of BPRT.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Sturgeon J, Trost Z, Ashar YK, et al. Brief pain reprocessing therapy for fibromyalgia: a feasibility, acceptability, and preliminary efficacy pilot. Reg Anesth Pain Med. 2025. PMID: 40973446. doi:10.1136/rapm-2025-107076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。